31 - 40 of 422 Results
Condition Status ˆ Requirements ˇ Location Near You ˇ
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

207263-Abacavir Use and Risk for Myocardial Infarction and Coronary Artery Disease: Meta-analysis of Data from Clinical Trials
207263-Abacavir Use and Risk for Myocardial Infarction and Coronary Artery Disease: Meta-analysis of Data from Clinical Trials
Human Immunodeficiency Virus (HIV)
Recruiting

No Limit

To find a center near you, please provide a Country or Postal Code.

208561-Understanding the dynamics of dual regimen ART in PLHIV in Spain
208561-Understanding the dynamics of dual regimen ART in PLHIV in Spain
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

208982-Dolutegravir/Rilpivirine, antiretroviral efficacy study using real-world data in subjects with human immunodeficiency virus (HIV)-1
208982-Dolutegravir/Rilpivirine, antiretroviral efficacy study using real-world data in subjects with human immunodeficiency virus (HIV)-1
Human Immunodeficiency Virus (HIV)
Active, not recruiting
0+

To find a center near you, please provide a Country or Postal Code.

A4001093-Safety And Efficacy Of Maraviroc In Patients For HIV Patients (Regulatory Post Marketing Commitment Plan)
A4001093-Safety And Efficacy Of Maraviroc In Patients For HIV Patients (Regulatory Post Marketing Commitment Plan)
Human Immunodeficiency Virus (HIV)
Recruiting

No Limit

To find a center near you, please provide a Country or Postal Code.

207445-An open label, multi-centre, Intensive Drug Monitoring of the safety and effectiveness of Dolutegravir in China
207445-An open label, multi-centre, Intensive Drug Monitoring of the safety and effectiveness of Dolutegravir in China
Human Immunodeficiency Virus (HIV)
Recruiting
17+

To find a center near you, please provide a Country or Postal Code.

201177-PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)
201177-PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

204861-An efficacy, safety, and tolerability study comparing dolutegravir plus lamivudine with dolutegravir plus tenofovir/emtricitabine in treatment naïve HIV infected subjects (Gemini 1)
204861-An efficacy, safety, and tolerability study comparing dolutegravir plus lamivudine with dolutegravir plus tenofovir/emtricitabine in treatment naïve HIV infected subjects (Gemini 1)
Human Immunodeficiency Virus (HIV)
Active, not recruiting

No Limit

To find a center near you, please provide a Country or Postal Code.

116265-PGx432 evaluation of the effect of UGT1A1 polymorphisms on dolutegravir pharmacokinetics: meta-analysis of Phase 1 studies ING111521, ING111603, ING111604, ING112934, ING113068, ING113096, ING114005, ING114819, ING113099
116265-PGx432 evaluation of the effect of UGT1A1 polymorphisms on dolutegravir pharmacokinetics: meta-analysis of Phase 1 studies ING111521, ING111603, ING111604, ING112934, ING113068, ING113096, ING114005, ING114819, ING113099
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

201637-Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)
201637-Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)
Human Immunodeficiency Virus (HIV)
Active, not recruiting
18+

To find a center near you, please provide a Country or Postal Code.

200056-A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (following Induction with an oral regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects
200056-A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (following Induction with an oral regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects